Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta - PubMed (original) (raw)
Review
Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta
E Joanna Steer et al. Acta Haematol. 2002.
Abstract
Acquired reciprocal chromosomal translocations that involve chromosome bands 5q31-33 are associated with a significant minority of patients with BCR-ABL-negative chronic myeloid leukemias. The most common abnormality is the t(5;12)(q33;p13), which fuses the ETV6/TEL gene to the platelet-derived growth factor receptor-beta (PDGFRB), a receptor tyrosine kinase that maps to 5q33. PDGFRB is disrupted by other translocations and to date four additional partner genes (H4, HIP1, CEV14 and Rab5) have been reported. Clinically, most patients present with a myeloproliferative disorder (MPD) with eosinophilia, eosinophilic leukemia or chronic myelomonocytic leukemia and thus fall into the broader category of myeloproliferative disorders/myelodysplastic syndromes (MPD/MDS). With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.
Copyright 2002 S. Karger AG, Basel
Similar articles
- Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.
Baxter EJ, Kulkarni S, Vizmanos JL, Jaju R, Martinelli G, Testoni N, Hughes G, Salamanchuk Z, Calasanz MJ, Lahortiga I, Pocock CF, Dang R, Fidler C, Wainscoat JS, Boultwood J, Cross NC. Baxter EJ, et al. Br J Haematol. 2003 Jan;120(2):251-6. doi: 10.1046/j.1365-2141.2003.04051.x. Br J Haematol. 2003. PMID: 12542482 - Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
Kulkarni S, Heath C, Parker S, Chase A, Iqbal S, Pocock CF, Kaeda J, Cwynarski K, Goldman JM, Cross NC. Kulkarni S, et al. Cancer Res. 2000 Jul 1;60(13):3592-8. Cancer Res. 2000. PMID: 10910073 - Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
Apperley JF, Gardembas M, Melo JV, Russell-Jones R, Bain BJ, Baxter EJ, Chase A, Chessells JM, Colombat M, Dearden CE, Dimitrijevic S, Mahon FX, Marin D, Nikolova Z, Olavarria E, Silberman S, Schultheis B, Cross NC, Goldman JM. Apperley JF, et al. N Engl J Med. 2002 Aug 15;347(7):481-7. doi: 10.1056/NEJMoa020150. N Engl J Med. 2002. PMID: 12181402 - Tyrosine kinase fusion genes in chronic myeloproliferative diseases.
Cross NC, Reiter A. Cross NC, et al. Leukemia. 2002 Jul;16(7):1207-12. doi: 10.1038/sj.leu.2402556. Leukemia. 2002. PMID: 12094244 Review. - Translocation t(5;12)(q31-q33;p12-p13): a non-random translocation associated with a myeloid disorder with eosinophilia.
Baranger L, Szapiro N, Gardais J, Hillion J, Derre J, Francois S, Blanchet O, Boasson M, Berger R. Baranger L, et al. Br J Haematol. 1994 Oct;88(2):343-7. doi: 10.1111/j.1365-2141.1994.tb05029.x. Br J Haematol. 1994. PMID: 7803280 Review.
Cited by
- Identification of potential bioactive phytochemicals for the inhibition of platelet-derived growth factor receptor β: a structure-based approach for cancer therapy.
Habib I, Sulaimani MN, Jairajpuri DS, Hussain A, Mohammad T, Alajmi MF, Shamsi A, Hassan MI. Habib I, et al. Front Mol Biosci. 2024 Oct 15;11:1492847. doi: 10.3389/fmolb.2024.1492847. eCollection 2024. Front Mol Biosci. 2024. PMID: 39473823 Free PMC article. - Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.
Nguyen L, Saha A, Kuykendall A, Zhang L. Nguyen L, et al. Cancers (Basel). 2024 Mar 31;16(7):1383. doi: 10.3390/cancers16071383. Cancers (Basel). 2024. PMID: 38611061 Free PMC article. Review. - A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia.
Jan M, Grinshpun DE, Villalba JA, Dal Cin P, Sykes DB, Iafrate AJ, Ebert BL, Hobbs GS, Nardi V. Jan M, et al. Blood Adv. 2020 Feb 11;4(3):445-448. doi: 10.1182/bloodadvances.2019001182. Blood Adv. 2020. PMID: 31999327 Free PMC article. - Rearrangement of PDGFRβ gene in a patient with Ph-negative chronic myeloid leukemia t(5;12)(q33;p13) in imatinib mesylate treatment-free remission: a case report.
Zheng J, Huang J, Xiao Y, Wu X, Wang K, Feng C, Gao K. Zheng J, et al. Int J Clin Exp Pathol. 2019 Jun 1;12(6):2284-2287. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934053 Free PMC article. - Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia.
Michel C, Mack EK, Mais CN, Fritz LV, Wang Y, Jehn LB, Hühn SK, Simon C, Inselmann S, Marquardt A, Kremer J, Wollmer E, Sohlbach K, Neubauer A, Brendel CA, Haferlach C, Bange G, Burchert A. Michel C, et al. Haematologica. 2020 Aug;105(8):e395-e398. doi: 10.3324/haematol.2019.237818. Epub 2019 Dec 2. Haematologica. 2020. PMID: 31792033 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous